Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Venous Thromboembolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00119457
What this trial is testing

Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

Who this might be right for
Venous ThromboembolismEmbolism and ThrombosisHip Fractures
vTv Therapeutics 300
Post-approval studies (Phase 4)Ended earlyNCT02396732
What this trial is testing

Aspirin and Enoxaparin for VTE in Trauma

Who this might be right for
Venous ThromboembolismThromboprophylaxisTrauma
University of Miami 31
Post-approval studies (Phase 4)WithdrawnNCT02054936
What this trial is testing

Evaluation of Wound Drainage After Knee or Hip Arthroplasty

Who this might be right for
Complications; Arthroplasty
University of Michigan
Testing effectiveness (Phase 2)WithdrawnNCT03393481
What this trial is testing

Prevention of Thromboembolic Events in Total Knee Replacement Patients

Who this might be right for
Thrombotic Disorders
Novartis Pharmaceuticals
Not applicableEnded earlyNCT03465735
What this trial is testing

Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

Who this might be right for
Acute DVT of Lower Extremity
Mayo Clinic 15
Large-scale testing (Phase 3)Ended earlyNCT01573169
What this trial is testing

PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients

Who this might be right for
Hemorrhagic StrokeVenous ThromboembolismDeep Venous Thrombosis
University Of Perugia 73
Testing effectiveness (Phase 2)UnknownNCT05189002
What this trial is testing

Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement

Who this might be right for
Venous Thromboembolism
PharmaDiall Ltd. 240
Testing effectiveness (Phase 2)Study completedNCT05752461
What this trial is testing

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Who this might be right for
Prevention of Venous Thromboembolism After Knee Arthroplasty
Beijing Suncadia Pharmaceuticals Co., Ltd 353
Large-scale testing (Phase 3)Study completedNCT01205932
What this trial is testing

Dose-confirmatory Bridging Study in Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 402
Large-scale testing (Phase 3)Looking for participantsNCT04257487
What this trial is testing

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

Who this might be right for
Venous ThromboembolismAnticoagulantElderly
Arianna Anticoagulazione Foundation 1,455
Not applicableEnded earlyNCT05819112
What this trial is testing

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Who this might be right for
Venous Thromboembolism
Sanofi 14,799
Post-approval studies (Phase 4)Study completedNCT00555438
What this trial is testing

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.

Who this might be right for
Major Orthopaedic Surgery and Renal Impairment
Centre Hospitalier Universitaire de Saint Etienne 451
Post-approval studies (Phase 4)Ended earlyNCT01727401
What this trial is testing

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

Who this might be right for
Medical PatientThrombocytopenia
G. d'Annunzio University 7
Testing effectiveness (Phase 2)Study completedNCT00396786
What this trial is testing

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 877
Post-approval studies (Phase 4)Study completedNCT04409834
What this trial is testing

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

Who this might be right for
COVID-19Venous ThromboembolismArterial Thrombosis
The TIMI Study Group 390
Testing effectiveness (Phase 2)Study completedNCT00074828
What this trial is testing

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

Who this might be right for
Total Knee ReplacementTotal Hip Replacement
Eli Lilly and Company 511
Testing effectiveness (Phase 2)Ended earlyNCT00790452
What this trial is testing

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT00362232
What this trial is testing

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.

Who this might be right for
Venous Thromboembolism
Bayer 3,148
Not applicableStudy completedNCT02213978
What this trial is testing

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients

Who this might be right for
Venous ThromboembolismHemorrhage
Beijing Chao Yang Hospital 1,114
Post-approval studies (Phase 4)Study completedNCT03158792
What this trial is testing

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Who this might be right for
Venous ThromboembolismRenal Impairment
Lebanese American University 32
Next Page